PSIP1
MOLECULAR TARGETPC4 and SRSF1 interacting protein 1
PSIP1 (PC4 and SRSF1 interacting protein 1) is targeted by 13 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting PSIP1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | myricetin-3-O-galactopyranoside [Supplementary Concept] | 1.79 | 5 |
| 2 | Cefixime | 1.79 | 5 |
| 3 | Levodopa | 1.79 | 5 |
| 4 | Luteolin 5,7,3',4'-tetrahydroxy-flavone, | 1.61 | 4 |
| 5 | Methylene Blue | 1.61 | 4 |
| 6 | Biotin | 1.10 | 2 |
| 7 | Ethidium | 1.10 | 2 |
| 8 | furylfuramide | 1.10 | 2 |
| 9 | Ampicillin Semi-synthetic derivative of penicillin that functions as | 0.69 | 1 |
| 10 | Demeclocycline | 0.69 | 1 |
| 11 | Edaravone | 0.69 | 1 |
| 12 | Methyldopa | 0.69 | 1 |
| 13 | alphitonin [Supplementary Concept] from | 0.69 | 1 |
About PSIP1 as a Drug Target
PSIP1 (PC4 and SRSF1 interacting protein 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 13 compounds with documented PSIP1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
PSIP1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.